Medicare Enrolled

Dr. Antoine Makhlouf, M.D.

Urology Physician · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1429 HIGHWAY 6 SOUTH, Sugar Land, TX 77478
7132735845
In practice since 2006 (19 years)
NPI: 1376586537 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Makhlouf from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makhlouf? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Makhlouf

Dr. Antoine Makhlouf is an urology physician in Sugar Land, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Makhlouf performed 4,729 Medicare services across 2,531 unique beneficiaries.

Between the years covered by Open Payments, Dr. Makhlouf received a total of $1,561 from 25 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Makhlouf is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 25% volume in TX $1,561 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,729
Medicare services
Top 25% in TX for urology physician
2,531
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~249 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
1,300 $0 $0
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
894 $65 $123
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
298 $36 $310
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
291 $94 $158
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
267 $3 $20
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
173 $41 $65
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
170 $8 $11
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
158 $121 $240
PSA test (prostate cancer screening) 153 $18 $58
Leuprolide acetate (for depot suspension), 7.5 mg 144 $134 $620
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
137 $22 $90
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
134 $179 $625
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
104 $8 $40
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
96 $72 $410
Additional urethral implant in prostate
Placement of an additional implant into the urethra within the prostate gland using an endoscope.
90 $38 $150
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
66 $25 $52
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
66 $8 $26
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
46 $26 $105
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
33 $11 $65
Urethral implant insertion in prostate
A single implant is placed into the urethra within the prostate gland using an endoscope.
29 $157 $660
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
20 $132 $650
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
16 $254 $1,290
Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters.
11 $216 $911
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
11 $244 $765
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
11 $311 $1,400
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
11 $184 $702
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
37.8% medium
61.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,561
Total received (2018-2024)
Avg $223/year across 7 years
Bottom 32% in TX for urology physician
25
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,496 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$175
2023
$411
2022
$164
2021
$272
2020
$112
2019
$298
2018
$129

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$282
Astellas Pharma US Inc
$201
Endo Pharmaceuticals Inc.
$193
PFIZER INC.
$144
Progenics Pharmaceuticals, Inc.
$110
Merck Sharp & Dohme LLC
$61
Antares Pharma, Inc.
$61
TOLMAR Pharmaceuticals, Inc.
$56
PROCEPT BioRobotics Corporation
$49
COLOPLAST CORP
$48
UROVANT SCIENCES INC
$41
Acerus Pharmaceuticals Corporation
$31
Clarus Therapeutics Inc.
$28
Olympus America Inc.
$27
Ferring Pharmaceuticals Inc.
$26
Ambu Inc.
$25
Travere Therapeutics, Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
Tolmar, Inc.
$23
Sumitomo Pharma America, Inc.
$22
UROGEN PHARMA, INC.
$21
Coloplast Corp
$18
Janssen Biotech, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$15
AKRIMAX PHARMACEUTICALS, LLC
$13
Top 3 companies account for 43.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · Altis · ELIGARD · ERLEADA · FIRMAGON · GEMTESA · JATENZO · JELMYTO · KEYTRUDA · MYRBETRIQ · NOCDURNA · Natesto · PYLARIFY · SEGLENTIS · SpeediCath · Stendra · Thiola · ULTOMIRIS · UROLIFT · UroLift System · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $33 per 100 Medicare services performed
Looking for an urology physician in Sugar Land?
Compare urology physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
170
Per 100K population
19.8
County median income
$113,409
Nearest hospital
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Makhlouf is a clinical cardiology specialist, with above-average Medicare volume (top 25% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Makhlouf experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Makhlouf performed 1,300 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Makhlouf receive payments from pharmaceutical companies?
Yes. Dr. Makhlouf received a total of $1,561 from 25 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makhlouf's costs compare to other urology physicians in Sugar Land?
Dr. Makhlouf's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makhlouf) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →